Our preliminary outcomes give a useful indication of the expected recovery course for COVID-19 tracheostomy patients, which is currently an unreported population. The preliminary mortality figure will rise with a longer follow-up period, but is still likely to be lower than the 31.5% 30-day mortality reported in a large trial of patients undergoing prolonged mechanical ventilation [9].  At present this study suggests that outcomes may be favourable when current guidance is adhered to.